Table 3.
Age-wise prevalence of adverse drug reactions
| ADRs | Age groups (years) | |
|---|---|---|
| 18-35 | 18-35 | |
| Gastrointestinal symptoms | ||
| Nausea and vomiting | 35 (39.32) | 48 (32.65) |
| Severe gastritis | 12 (13.48) | 7 (4.76) |
| Musculoskeletal disorders | ||
| Arthralgia | 1 (1.12) | 32 (21.76) |
| Skin and subcutaneous tissue disorders | ||
| Acne vulgaris | 12 (13.48) | 1 (0.68) |
| Dermatitis | 1 (1.12) | 6 (4.08) |
| Central nervous systems disorders | ||
| Peripheral neuropathy | 0 | 21 (14.28) |
| Giddiness | 14 (15.73) | 7 (4.76) |
| Endocrine disorders | ||
| Hypothyroidism | 5 (5.61) | 2 (1.36) |
| Gynecomastia | 1 (1.12) | 2 (1.36) |
| Psychiatric disorders | ||
| Psychosis | 4 (4.49) | 0 |
| Renal toxicity | ||
| Nephrotoxicity | 1 (1.12) | 2 (1.36) |
| Vestibular toxicities | ||
| Ototoxicity | 0 | 6 (4.08) |
| Tinnitus and mild hearing loss | 3 (3.37) | 13 (8.84) |
| Total (n) | 89 | 147 |
n=236. ADRs: Adverse drug reaction